![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
Seoul National Hospital Korea Otsuka Pharmaceutical Co.,Ltd. |
---|---|
Information provided by: | Seoul National Hospital |
ClinicalTrials.gov Identifier: | NCT00569504 |
The purpose of this study is to assess the cross-sectional prevalence of the metabolic syndrome in patients with schizophrenia taking antipsychotics.
Condition |
---|
Metabolic Syndrome Schizophrenia |
Study Type: | Observational |
Study Design: | Case-Only, Cross-Sectional |
Official Title: | Prevalence of the Metabolic Syndrome in Patients With Schizophrenia Taking Antipsychotics |
blood sampling
Estimated Enrollment: | 1000 |
Study Start Date: | December 2007 |
Estimated Study Completion Date: | September 2008 |
Groups/Cohorts |
---|
A, observatoin
inpatients and outpatients in Seoul National Hospital
|
Schizophrenic patients taking any kind of antipsychotics for at least 1 year at the Seoul National Hospital will be participated in this study.
we are planning to enroll approximately 1000 patients with schizophrenia.
For each subject
we will calculate the rates of patients who meet the critera for the Metabolic syndrome.
2 or more of followings
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
DSM-IV diagnosis of schizophrenia
Inclusion Criteria:
Contact: Shi Hyun Kang, M.D. | 82-2-2204-0326 | drshe@hanmail.net |
Korea, Republic of | |
Seoul National Hospital | Recruiting |
Seoul, Korea, Republic of, 139-757 | |
Contact: Shi Hyun Kang, M.D. 82-2-2204-0326 drshe@hanmail.net |
Study Director: | Jong-il Lee, M.D. | Seoul National Hospital |
Responsible Party: | Seoul National Hospital ( Shi Hyun Kang ) |
Study ID Numbers: | snh001, PMSPSTA |
Study First Received: | December 6, 2007 |
Last Updated: | July 14, 2008 |
ClinicalTrials.gov Identifier: | NCT00569504 |
Health Authority: | Korea: Food and Drug Administration |
schizophrenia antipsychotics metabolic syndrome prevalence |
Schizophrenia Mental Disorders Psychotic Disorders Schizophrenia and Disorders with Psychotic Features |
Pathologic Processes Disease Syndrome |